Advertisement

Topics

Biotechnology Products Reports

08:10 EDT 26th June 2017 | BioPortfolio

Febrile Neutropenia Market: By Therapeutics Molecule Type Pegfilgrastim, Vancomycin hydrochloride, Filgrastim biosimilars, Pegfilgrastim biosimilars, Stimuxen and Others By RegionForecast 20162021 [Updated: 29022016] Prices from USD $5250

Febrile neutropenia is the development of fever with sign of infection and is one of the most severe complications during cancer chemotherapy. It is mainly caused by infectious agents such as gram positive and gram negative bacteria. This results in significant reduction of white blood cell count in the patients. Blood test is used to determine the number of white blood cells and to diagnose febri...

Biopharmaceutical Market: By Source Unicellular Multicellular Systems By Products Vaccines, Enzymes, Others Manufacturing Process Single Multi Use Systems Application Oncology, Cardiology, Others End Users Hospitals, OthersForecast20172022 [Updated: 190

Biopharmaceuticals are large and complex products isolated from genetically modified living organisms. Recently, biologics or biopharmaceuticals is one of the fastest growing sectors of pharmaceutical industries, owing to its innovative nature, greater safety and efficacy compared to traditional drugs.The market for Biopharmaceutical is classified into three categories based on source, type of pro...

Northwest Biotherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 03052017] Prices from USD $350

Northwest Biotherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Northwest Biotherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership trans...

Aeglea BioTherapeutics Inc AGLE Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryAeglea BioTherapeutics Inc Aeglea BioTherapeutics, formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company's product pipeline comprises AEB1102, AEB3103, AEB2109, and AEB4104. It develops engineered human enzymes to target and degrade amino acids in t...

Celltrion Inc 068270 Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 16032017] Prices from USD $250

SummaryCelltrion Inc Celltrion is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody bios...

Protagen Protein Services GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 21022017] Prices from USD $250

SummaryProtagen Protein Services GmbH PPS, a subsidiary of Zukunftsfonds Heilbronn GmbH Co KG, is a contract research organization that focuses on protein analytics. The company offers services including protein characterization, services for biopharmaceuticals, biosimilars services and analytical methods. Its protein characterization services include protein quantification, protein primary struc...

Aeglea BioTherapeutics Inc AGLE Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryAeglea BioTherapeutics Inc Aeglea BioTherapeutics, formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops engineered human enzymes and companion diagnostics for the treatment of cancer. The company by combining amino acid depletion therapy with codevelopment of diagnostics has identified the metabolic reprogramming of cancer as an opportunity with improved th...

Celltrion Inc 068270 Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryCelltrion Inc Celltrion is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody bios...

Quick Search
Advertisement
 

review and buy Biotechnology Products market research data and corporate reports here